Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0 ビュー
• 07/04/23
0
0
埋め込む
administrator
加入者
Earn CME for related activities: https://www.naccme.com/oln
This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.
© 2018 NACCME, an HMP Company
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント